Table 3.

Multivariate Cox regression of discontinuation after 1 year of Secukinumab treatment in the entire population.

	β	SE	Wald	p-value	HR (95%CI)
Diagnosis (Ref. AxSpA)	2.511	1.042	5.812	0.016	12.32 (1.60–94.9)
Obesity (Ref. No)	0.933	0.479	3.795	0.051	2.54 (0.99–6.50)
Gender (Ref. Male)	−1.229	1.047	1.377	0.241	0.29 (0.04–2.28)
Interactions
Obesity*gender   (Ref. No woman obese)	−3.075	1.147	7.193	0.007	0.046 (0.005–0.44)
Diagnosis*gender   (Ref. No man PsA)	−3.508	1.186	8.752	0.003	0.03 (0.003–0.31)

AxSpA, Spondyloarthritis; PsA, Psoriatic arthritis; SE, standard error.